Ameliora Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.78M Buy
1,486
+196
+15% +$200K 0.53% 38
2026
Q1
$1.19M Sell
1,290
-37
-3% -$37.5K 0.38% 43
2025
Q4
$1.43M Buy
1,327
+22
+2% +$21K 0.43% 41
2025
Q3
$996K Sell
1,305
-2,482
-66% -$1.85M 0.33% 46
2025
Q2
$2.95M Sell
3,787
-712
-16% -$553K 1.06% 27
2025
Q1
$3.72M Sell
4,499
-53
-1% -$44.1K 1.4% 19
2024
Q4
$3.51M Buy
4,552
+453
+11% +$375K 1.32% 23
2024
Q3
$3.63M Sell
4,099
-488
-11% -$439K 1.51% 19
2024
Q2
$4.15M Buy
4,587
+2,262
+97% +$1.81M 1.89% 17
2024
Q1
$1.81M Buy
2,325
+796
+52% +$566K 0.82% 39
2023
Q4
$891K Buy
1,529
+717
+88% +$419K 0.44% 42
2023
Q3
$436K Buy
812
+172
+27% +$88.6K 0.26% 52
2023
Q2
$300K Sell
640
-400
-38% -$168K 0.19% 71
2023
Q1
$357K Sell
1,040
-3,540
-77% -$1.19M 0.21% 73
2022
Q4
$1.68M Sell
4,580
-620
-12% -$220K 0.9% 37
2022
Q3
$1.69M Buy
+5,200
New +$1.65M 0.91% 34

Other funds holding LLY

Ameliora Wealth Management's LLY Position: Q2 2026 in Review

Ameliora Wealth Management increased its Eli Lilly (LLY) stake by 15% in Q2 2026, buying an estimated $200K and bringing the position to 1,486 shares worth $1.78M. The position accounts for 0.53% of the portfolio, ranked #38.

Ameliora Wealth Management first reported a position in LLY in Q3 2022 and has held it in 16 quarters since. The position peaked at $4.15M in Q2 2024. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Ameliora Wealth Management held 1,486 shares of Eli Lilly worth $1.78M as of Q2 2026.
  • Ameliora Wealth Management bought 196 Eli Lilly shares in Q2 2026, an estimated $200K.
  • Eli Lilly made up 0.53% of Ameliora Wealth Management's portfolio in Q2 2026, its #38 holding.
  • Ameliora Wealth Management first reported a position in Eli Lilly in Q3 2022 and has held it in 16 quarters since.
  • Ameliora Wealth Management's Eli Lilly position peaked at $4.15M in Q2 2024.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Ameliora Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.